Live Vital review

Live Vital describes a clinician-supervised practice with GLP-1, NAD+ and glutathione protocols, alongside a wider peptide menu. It remains outside the recommendations because that menu includes BPC-157, TB-500, MOTS-c, CJC-1295 with ipamorelin, injectable GHK-Cu, compounded tesamorelin and blends containing restricted ingredients. The concern is routine commercial compounding, not whether a clinician can discuss a molecule or whether an authorized research pathway could exist. A prescription and a pharmacy claim do not automatically establish compliance for every ingredient. Ask exactly what is proposed, which preparation is being dispensed and what regulatory basis the prescriber and pharmacy rely on.

The NAD+ page sells a three-month protocol whose monthly equivalent is $149. The glutathione protocol also covers three months, with a monthly equivalent of $99.67. Those equivalents divide a total commitment; they should not be mistaken for separately cancellable monthly installments. The reviewed product pages do not establish a one-month alternative. Confirm whether the whole protocol is collected before clinical review, how much medication arrives in each shipment, and what happens if treatment is changed or stopped. A protocol length is not evidence that a single opened vial remains suitable for that entire time.

The GLP-1 products instead describe ten-week starting protocols. Their cards label a monthly figure obtained by dividing the bundle total by three, even though ten weeks is shorter than three calendar months. That makes the card unsuitable for a direct monthly comparison without qualification. Use the actual bundle charge, its stated duration and the prescribed quantity rather than assuming that three equal installments are available. Dose changes and later protocols can alter the cost. These are compounded preparations, distinct from approved Wegovy, Ozempic, Zepbound or Mounjaro products, and approval evidence for those brands does not establish the safety or effectiveness of Live Vital’s preparation.

The FAQ offers a ten-minute online intake or a free fifteen-minute phone consultation first. It names Patrick Taylor as the medical-team lead and describes a licensed clinician reviewing each case. Those are provider representations, not a separate credential verification. The stated review window is 24 to 48 hours; pharmacy processing can take five to seven days before overnight cold-pack shipping. An overnight shipping service is therefore not a promise of next-day arrival after intake. The product pages include care-team messaging. Confirm the contact arrangement for adverse effects and the actual dispensing pharmacy, since a general licensed-pharmacy description does not identify the facility handling your order.

The refund policy leaves an important gap: its section about payment before clinician review and refunds when no prescription is issued still contains an unfinished placeholder. Do not infer a full money-back promise from the requirement for clinical approval. The terms say payment is due at service unless otherwise agreed, and medication or labs are generally non-refundable once ordered or dispensed. The separate refund page says compounded or shipped medication is generally non-refundable after the prescription reaches the pharmacy. Cancellation takes effect at the end of the current billing period. Obtain a written answer about ineligibility and the point at which a charge becomes non-refundable before submitting payment.

The practice is cash-pay and says HSA or FSA funds may cover eligible expenses. The states page lists the states served, and access still depends on a clinician licensed where the patient is located. Its FAQ tells patients to follow the pharmacy label’s storage and beyond-use instructions and contact the team if a protocol would outlast the printed date. That is a reason to obtain product-specific clarification, not to extend vial use from a general protocol name. FDA also warns about dosing errors and quality problems with unapproved GLP-1 preparations. Service convenience, a named clinician and a cold shipping method do not eliminate those risks or prove a longevity benefit.